[Federal Register: May 26, 2005 (Volume 70, Number 101)]
[Notices]
[Page 30420-30421]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr26my05-45]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
Meeting of the Uniform Formulary Beneficiary Advisory Panel
AGENCY: Department of Defense, Assistant Secretary of Defense (Health
Affairs).
ACTION: Notice; meeting of the Uniform Formulary Beneficiary Advisory
Panel.
-----------------------------------------------------------------------
SUMMARY: This notice announces a meeting of the Uniform Formulary
Beneficiary Advisory Panel. The panel will review and comment on
recommendations made to the Director, TRICARE Management Activity, by
the Pharmacy and Therapeutics Committee regarding the Uniform
Formulary. The meeting will be open to the public. Seating is limited
and will be provided only to the first 220 people signing in. All
persons must sign in legibly. Notice of this meeting is required under
the Federal Advisory Committee Act.
DATES: Monday, June 27, 2005, from 8 a.m. to 4 p.m.
ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue NW.,
Washington, DC 20004.
FOR FURTHER INFORMATION CONTACT: Rich Martel, TRICARE Management
Activity, Pharmacy Operations, Beneficiary Advisory Panel, Suite 810,
5111 Leesburg Pike, Falls Church, VA 22041, telephone 703-681-0064 ext.
3672, fax 703-681-1242, or e-mail at richard.martel@tma.osd.mil.
SUPPLEMENTARY INFORMATION: The Uniform Formulary Beneficiary Advisory
Panel will only review and comment on the development of the uniform
formulary as reflected in the recommendations of the Pharmacy and
Therapeutics Committee coming out of that body's meeting in May 2005.
The DoD P&T information and subject matter concerning drug classes
reviewed for that meeting are available at http://www.pec.ha.osd.mil The website for the Beneficiary Advisory Panel is at http://www.tricare.osd.mil/pharmacy/bap.
Any private citizen is permitted to
file a written statement with the advisory panel. Statements must be
submitted electronically to The Uniform Formulary Beneficiary Advisory
Panel, c/o Mr. Richard Martel, richard.martel@tma.osd.mil. In order to
[[Page 30421]]
be considered by the panel prior to the meeting, statements must be
submitted electronically no later than June 21, 2005. Any private
citizen is permitted to speak at the Beneficiary Advisory Panel
meeting, time permitting. One hour has been reserved for public
comments, and speaking times will be assigned on a first-come, first-
served basis. The amount of time allocated to a speaker will not exceed
five minutes. Private citizens wishing to speak at the meeting may sign
up at the meeting on a first-come, first-served basis.
Dated: May 20, 2005.
Jeannette Owings-Ballard,
OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 05-10490 Filed 5-25-05; 8:45 am]
BILLING CODE 5001-06-P